An integrated genomic and metabolomic approach for defining survival time in adult oligodendrogliomas patients.
Caroline BundMariana Guergova-KurasA Ercument CicekFrançois-Marie MoussalliehNassim Dali-YoucefMartial PiottoPilar SchneiderRémy HellerNatacha Entz-WerleBenoît LhermitteMarie-Pierre ChenardRoland SchottFrançois ProustGeorges NoëlIzzie Jacques NamerPublished in: Metabolomics : Official journal of the Metabolomic Society (2019)
HRMAS NMR spectroscopy provides accurate information on the metabolomics of oligodendrogliomas, making it possible to find new biomarkers indicative of survival. It enables rapid characterization of intact tissue and could be used as an intraoperative method.